lovastatin has been researched along with Carcinoma, Anaplastic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Robbins, RJ | 1 |
| Chang, TC; Lai, SM; Tsai, YF; Wang, CY; Zhong, WB | 1 |
| Fowler, CJ; Sandberg, A | 1 |
| Ajith, TA; Soja, M | 1 |
| Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M | 1 |
| Bifulco, M; Ferraro, A; Fusco, A; Iacuzzo, I; Libertini, S; Portella, G; Vitale, M | 1 |
| Diamond, AM; Hatfield, DL; Jaffe, D; Murray, JL; Safa, AR; Samuels, BL | 1 |
| Broitman, SA; Fabricant, M | 1 |
1 review(s) available for lovastatin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Statins sentence thyroid cancer cells to death rho.
Topics: Carcinoma; Cell Death; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; rho GTP-Binding Proteins; Thyroid Neoplasms | 2003 |
8 other study(ies) available for lovastatin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.
Topics: Apoptosis; Carcinoma; Cell Differentiation; Cell Survival; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Microscopy, Electron, Scanning; Protein Prenylation; Radioimmunoassay; Thyroglobulin; Thyroid Neoplasms; Tumor Cells, Cultured | 2003 |
Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin.
Topics: Amidohydrolases; Animals; Anticholesteremic Agents; Arachidonic Acids; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Cholesterol; Embryo, Mammalian; Endocannabinoids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Polyunsaturated Alkamides; Serum Albumin, Bovine | 2005 |
A comparative study on the antimutagenicity of atorvastatin and lovastatin against directly acting mutagens.
Topics: Anticarcinogenic Agents; Antimutagenic Agents; Atorvastatin; Carcinoma; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Lovastatin; Mutagenesis; Mutagenicity Tests; Mutagens; Mutation; Pyrroles; Salmonella; Salmonella typhimurium | 2006 |
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid | 2007 |
Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Carcinoma; Cells, Cultured; Combined Modality Therapy; Female; Humans; Lovastatin; Mice; Mice, Nude; Oncolytic Virotherapy; Oncolytic Viruses; Thyroid Neoplasms; Viral Vaccines; Virus Replication; Xenograft Model Antitumor Assays | 2007 |
Lovastatin effects on human breast carcinoma cells. Differential toxicity of an adriamycin-resistant derivative and influence on selenocysteine tRNAS.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Doxorubicin; Drug Resistance, Neoplasm; Glutathione Peroxidase; Humans; Lovastatin; RNA, Transfer, Amino Acid-Specific; Selenium; Tumor Cells, Cultured | 1996 |
Evidence for deficiency of low density lipoprotein receptor on human colonic carcinoma cell lines.
Topics: Antibodies, Monoclonal; Carcinoma; Cholesterol; Colonic Neoplasms; Humans; In Vitro Techniques; Lipoproteins, LDL; Lovastatin; Receptors, LDL; Tumor Cells, Cultured | 1990 |